Abstract
OBJECTIVE--To investigate the current and likely future provision of screening services for risk factors for coronary heart disease in retail pharmacies in Sheffield. DESIGN--This was a questionnaire survey asking about screening tests currently offered, price charged per test, likely future provision of screening tests, the action respondents would take upon finding an abnormal test result, whether the pharmacy was owner-run, franchised, or part of a commercial chain, and inviting open comments from respondents. SETTING--All retail pharmacy premises on the Sheffield Family Health Services Authority list. RESULTS--Seventy seven responses were obtained to 102 questionnaires distributed. Only nine of these currently offered any screening test other than pregnancy testing, although 37 indicated that they might offer tests in the future. Thirty nine were not offering screening and had no plans to do so. Pharmacies offering or likely to offer screening tests were mainly owner-run. All pharmacists who replied to the question asking about their action upon finding abnormal result (33) reported that they would advise the patient to see a doctor. The most frequent comments made by pharmacists were about the commercial viability of screening in pharmacies and the lack of space available to ensure patient privacy and confidentiality during screening. CONCLUSIONS--Screening in retail pharmacies would probably be a commercial failure unless doctors were able to contract for screening services from pharmacies. Evidence from this study and others, however, leads us to question the desirability of this option.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Broughton P. M., Bullock D. G., Cramb R. Quality of plasma cholesterol measurements in primary care. BMJ. 1989 Feb 4;298(6669):297–298. doi: 10.1136/bmj.298.6669.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Morris J. N., Kagan A., Pattison D. C., Gardner M. J. Incidence and prediction of ischaemic heart-disease in London busmen. Lancet. 1966 Sep 10;2(7463):553–559. doi: 10.1016/s0140-6736(66)93034-0. [DOI] [PubMed] [Google Scholar]
- Shaper A. G., Pocock S. J., Walker M., Cohen N. M., Wale C. J., Thomson A. G. British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. Br Med J (Clin Res Ed) 1981 Jul 18;283(6285):179–186. doi: 10.1136/bmj.283.6285.179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shaper A. G., Pocock S. J., Walker M., Phillips A. N., Whitehead T. P., Macfarlane P. W. Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Community Health. 1985 Sep;39(3):197–209. doi: 10.1136/jech.39.3.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shepherd J., Betteridge D. J., Durrington P., Laker M., Lewis B., Mann J., Miller J. P., Reckless J. P., Thompson G. R. Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association. Br Med J (Clin Res Ed) 1987 Nov 14;295(6608):1245–1246. doi: 10.1136/bmj.295.6608.1245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith G. D., Song F., Sheldon T. A. Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ. 1993 May 22;306(6889):1367–1373. doi: 10.1136/bmj.306.6889.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spencer J. A., Edwards C. Pharmacy beyond the dispensary: general practitioners' views. BMJ. 1992 Jun 27;304(6843):1670–1672. doi: 10.1136/bmj.304.6843.1670. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tunstall-Pedoe H. Who is for cholesterol testing? Test selectively those who will benefit most. BMJ. 1989 Jun 17;298(6688):1593–1594. doi: 10.1136/bmj.298.6688.1593. [DOI] [PMC free article] [PubMed] [Google Scholar]